Polyplex Corporation Reports ₹2,250 Crore Q1 FY27 Revenue
Key highlights
- Polyplex reported Q1 FY27 revenue of ₹2,250 crore, up 30% year-on-year.
- Normalized EBITDA was ₹362 crore in Q1 FY27.
- Normalized EBITDA margin improved to 16% from an 8% FY26 reference.
- Reported Q1 FY27 net profit was ₹171.1 crore.
powered by IRIS

Polyplex Corporation Limited reported consolidated Q1 FY27 revenue of ₹2,250 crore, up 30% year-on-year, while normalized EBITDA reached ₹362 crore and the normalized EBITDA margin improved to 16% from 8% in FY26. The figures were outlined in the investor presentation filed on August 13, 2026, for the quarter ended June 30, 2026.
Know Polyplex Corporation inside out
Results, valuation, peers and who's buying, in one view.
What did Polyplex report for Q1 FY27?
Polyplex reported a substantial improvement in its first-quarter financial performance, with revenue growth supported by improved realisations and a focus on specialty films. The company presented normalized EBITDA of ₹362 crore on revenue of ₹2,250 crore, translating into a 16% normalized EBITDA margin.
The presentation described the revenue increase as 30% year-on-year. Separately, the reported Q1 FY27 results stated revenue from operations of ₹2,254 crore, up 29.6% year-on-year, and net profit of ₹171.1 crore. The slight difference between revenue figures reflects the metrics presented in the available disclosures, with the investor presentation citing ₹2,250 crore.
How did Polyplex improve its operating performance?
Polyplex attributed the stronger quarter to improved realisations and its specialty-film strategy. Higher realisations can directly support profitability in film manufacturing because changes in selling prices affect revenue generation on existing production volumes.
The company also cited precautionary buying amid geopolitical uncertainty as a contributor to demand visibility. This indicates that customer procurement activity was supported by efforts to secure supply in an uncertain global environment. The presentation did not provide a product-wise or geography-wise revenue split for this demand effect.
Management expressed confidence in Polyplex's market positioning and the resilience of its margins. However, the presentation also identified risks that could affect operating conditions, including raw-material cost increases, geopolitical uncertainty and global overcapacity in film substrates.
Got a follow-up? Ask IRIS
What is Polyplex investing in next?
Polyplex's stated growth programme includes a new PET film line in the United States, referenced as a 2025 project, and an India capacity expansion programme planned for 2026-27. These projects form part of the company's ongoing capital-expenditure agenda.
The company is also continuing to focus on its D-PAC specialty portfolio. The presentation positioned specialty films as an important operational focus, alongside the broader objective of maintaining market positioning. No investment amount, commissioning timeline or incremental capacity figure for the India expansion was included in the information provided.
The capacity programme matters because the film-substrate industry faces global overcapacity, a risk specifically noted by Polyplex. New capacity can support product availability and strategic growth, but its financial contribution depends on market demand, pricing and operating costs.
What do the results mean for investors and the film industry?
For investors, the main Q1 FY27 datapoint is the increase in normalized EBITDA margin to 16% from the 8% reference for FY26. Revenue growth and the higher margin together indicate improved operating performance during the reported quarter, although the available material does not provide a comparable prior-year EBITDA amount.
The results also show the importance of product mix and realisations in the packaging-film business. Polyplex operates in an environment where raw material prices and global supply additions can influence margins. The company's specialty-film focus is therefore relevant to its stated strategy, while not eliminating exposure to broader substrate-market conditions.
Customers and industry participants may also track the company's planned additions in the US and India. The presentation confirms these initiatives but does not quantify their expected revenue or profitability effect. As a result, the disclosed information supports an assessment of current performance and investment direction, rather than a financial forecast.
Conclusion
Polyplex delivered Q1 FY27 revenue of ₹2,250 crore and normalized EBITDA of ₹362 crore, with the normalized EBITDA margin improving to 16%. Improved realisations, specialty-film focus and precautionary buying were identified as factors supporting the quarter, while raw-material costs, geopolitical uncertainty and substrate overcapacity remain relevant risks.
Investors will next watch progress on the India expansion scheduled for 2026-27, the operational development of the US PET line, and whether the company can sustain its margin performance amid raw-material and global supply pressures. The presentation did not disclose investment values, capacity volumes or financial targets for these projects.


